TRHR: Thyrotropin-releasing hormone receptor
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Receptor for thyrotropin-releasing hormone (TRH).
- Drugs that act on it: 3
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Protirelin | Approved | Thyrotropin-releasing hormone receptor agonist | Agonist | — |
| Rovatirelin | — | Thyrotropin-releasing hormone receptor agonist | Agonist | — |
| Taltirelin | — | Thyrotropin-releasing hormone receptor agonist | Agonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Hypothyroidism, congenital, nongoitrous, 7
- 0.72
- Central nervous system disorder
- 0.46
- Cerebellar ataxia
- 0.33
- Hypertensive disorder
- 0.32
- Smoking initiation
- 0.30
- Liver disorder
- 0.29
- Spinocerebellar tract degeneration
- 0.28
- Parkinson disease
- 0.26
- Lung disorder
- 0.26
- Diabetic neuropathy
- 0.25
Drugs and mechanisms are from ChEMBL CHEMBL1810 (CC BY-SA 3.0). Gene name, function (UniProt P34981, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets